Laura Meiss-Heydmann

发表

JAK1 promotes HDV replication and is a potential target for antiviral therapy.

E. Felli, J. Lucifora, Eloi R. Verrier, 2023, Journal of hepatology.

CAM-A-dependent HBV core aggregation induces apoptosis through ANXA1

Y. Debing, Eloi R. Verrier, D. B. Kum, 2024, JHEP Reports.

Targeting the liver clock improves fibrosis by restoring TGF-β signaling.

K. Chayama, E. Crouchet, H. Aikata, 2024, Journal of hepatology.